Search research articles
Contact Us
Filters
Showing results (341-350 of 346) with videos related to
Page
of 35
Sort By:
You have reached the last page of results.
This site can display upto 346 results.
Cellular Microbiology
|
September 3, 2015
Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites
Sanna R Rijpma, Maarten van der Velden, Maria González-Pons, et al.
Journal of Crohn'S & Colitis
|
June 13, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
Fenna M Jansen, Reinier C A van Linschoten, Wietske Kievit, et al.
Digestive Diseases and Sciences
|
April 9, 2024
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
The Lancet. Gastroenterology & Hepatology
|
February 3, 2023
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Journal of Crohn'S & Colitis
|
December 15, 2022
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
Femke Crouwel, Melek Simsek, Marjon A de Boer, et al.
Human Genetics
|
May 24, 2024
The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes
Niels Vos, Sadegheh Haghshenas, Liselot van der Laan, et al.
Page
of 35
Search research articles
Search
Showing results (341-350 of 346) with videos related to
Sort By:
Page
of 35
You have reached the last page of results.
This site can display upto 346 results.
Cellular Microbiology
|
September 3, 2015
Multidrug ATP-binding cassette transporters are essential for hepatic development of Plasmodium sporozoites
Sanna R Rijpma, Maarten van der Velden, Maria González-Pons, et al.
Journal of Crohn'S & Colitis
|
June 13, 2023
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial
Fenna M Jansen, Reinier C A van Linschoten, Wietske Kievit, et al.
Digestive Diseases and Sciences
|
April 9, 2024
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
The Lancet. Gastroenterology & Hepatology
|
February 3, 2023
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial
Reinier C A van Linschoten, Fenna M Jansen, Renske W M Pauwels, et al.
Journal of Crohn'S & Colitis
|
December 15, 2022
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease
Femke Crouwel, Melek Simsek, Marjon A de Boer, et al.
Human Genetics
|
May 24, 2024
The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes
Niels Vos, Sadegheh Haghshenas, Liselot van der Laan, et al.
Page
of 35